« Back to Record
Beck, J. T., Hortobagyi, G. N., Campone, M., Lebrun, F., Piccart-Gebhart, M., Deleu, I., Rugo, H., Pistilli, B., Masuda, N., Hart, L. L., Melichar, B., Dakhil, S., Geberth, M., Nunzi, M., Heng, D. Y. C., Brechenmacher, T., El-Hashimy, M., Douma, S., & Ringeisen, F. (2014). Everolimus plus exemestane as first-line therapy in HR+, HER2- advanced breast cancer in BOLERO-2. Breast cancer research and treatment, 143(3), 459-467. doi:10.1007/s10549-013-2814-5
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/195360



